April 2018 - AusCann Group Holdings Limited (ASX:AC8) is bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of products and aiming is to produce and provide high quality, economical and clinically validated cannabis medicines to Australian patients.

Managing Director Elaine Darby introduces AusCann Group Holdings and outlines the company's operations, operational priorities, industry positioning, global opportunity and regulatory outlook.

To learn more please visit: www.auscann.com.au